Keywords
Down Syndrome
Risk factors
Child
Adolescent
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the association between cardiometabolic risk factors and treated hypothyroidism in children and adolescents with Down Syndrome. Methods: Of 51 patients with Down Syndrome, 20 met the eligibility criteria and participated in a cross-sectional study, underwent clinical examination, laboratory tests aimed at evaluating thyroid function, insulin resistance and lipids. Results: Age ranged from 4.0 to 19 years (mean:11.6), 14 were pubertal, 8(40%) had acanthosis nigricans, 7(35%) were overweight/obese and 3(15%) had increased abdominal circumference, Z-BMI was higher in males (p=0.034). Elevations of insulin were observed in 7(35%) patients of the HOMA-IR index in 5(25%), of triglycerides in 12(60%), ferritin in 6(30%), reduction of HDL-cholesterol in 10(50%). Triglycerides and non-HDL-cholesterol were significantly higher in males. Free T4 concentrations were higher in females (p=0.043). The variables Z-BMI and waist circumference showed an inverse correlation with Free T4 and Total T3 and a direct correlation with insulin, ferritin and triglycerides concentrations. Conclusion: The data from the present study indicate the need to optimize the treatment of hypothyroidism, prevention and reduction of cardiometabolic risk factors, especially in males.
References
AMR NH. Thyroid Disorders in Subjects with Down Syndrome: An Update. Acta Biomedica, 2018; 89(1): 132-139.
ANTONARAKIS SE, et al. Down syndrome. Nature Reviews Disease Primers, 2020; 6(1): 9.
AVERSA T, et al. Peculiarities of presentation and evolution over time of Hashimoto's thyroiditis in children and adolescents with Down's syndrome. Hormones (Athens), 2015; 14(3): 410-416.
BERTAPELLI F, et al. Body mass index reference charts for individuals with Down syndrome aged 2-18 years. Jornal de Pediatria (Rio de Janeiro), 2017; 93(1): 94-99.
BERTAPELLI F, et al. Overweight and obesity in children and adolescents with Down syndrome-prevalence, determinants, consequences, and interventions: A literature review. Research in Developmental Disabilities, 2016; 57: 181-192.
BLOCH KV, et al. Prevalences of hypertension and obesity in Brazilian adolescents. Revista de Saúde Pública, 2016; 50(1): 9.
BRASIL. Sociedade Brasileira de Pediatria. Manual de Orientação: Hipertensão arterial na infância e adolescência. 2019. Disponível em: https ://www.sbp.com.br/fileadmin/user_upload/21635c-MO_-_Hipertensao_Arterial_Infanc_e_Adolesc.pdf. Acessado em: 10 de julho de 2024.
BROERS CJ, et al. Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus. Journal of Clinical Immunology, 2012; 32(2): 323-329.
CILHOROZ BT, et al. Cardiovascular physiology and pathophysiology in Down syndrome. Physiological Research, 2022; 71(1): 1-16.
DIMOPOULOS K, et al. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus. Circulation, 2023; 147(5): 425-441.
EL GEBALI HH, et al. Leptin, insulin like growth factor-1 and thyroid profile in a studied sample of Egyptian children with Down syndrome. Egyptian Journal of Medical Human Genetics, 2014; 15(2): 131-138.
FARIA CD, et al. TSH neurosecretory dysfunction (TSH-nd) in Down syndrome (DS): low risk of progression to Hashimoto's thyroiditis. Arquivos Brasileiros de Endocrinologia & Metabologia, 2011; 55(8): 628-631.
GARCÍA CUARTERO B, et al. Indice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular [The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children]. Anales de Pediatría (Barcelona), 2007; 66(5): 481-490.
GIMÉNEZ-BARCONS M, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. Journal of Immunology, 2014; 193(8): 3872-3879.
GONZÁLEZ-AGÜERO A, et al. Dimorfismo sexual en grasa corporal en adolescentes con síndrome de Down. Revista Española de Obesidad, 2010; 8(1): 214-219.
HETMAN M, et al. Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies. Pediatric Endocrinology Diabetes and Metabolism, 2023; 29(3): 143-155.
IUGHETTI L, et al. Ten-year longitudinal study of thyroid function in children with Down's syndrome. Hormone Research in Paediatrics, 2014; 82(2): 113-121.
LUTON D, et al. Thyroid function in fetuses with down syndrome. Hormone Research in Paediatrics, 2012; 78(2): 88-93.
MADEIRA IR, et al. Ponto de corte do índice Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) avaliado pela curva Receiver Operating Characteristic (ROC) na detecção de síndrome metabólica em crianças pré-púberes com excesso de peso [Cut-off point for Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index established from Receiver Operating Characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children]. Arquivos Brasileiros de Endocrinologia & Metabologia, 2008; 52(9): 1466-1473.
MAGGE SN, et al. Leptin levels among prepubertal children with Down syndrome compared with their siblings. Jornal de Pediatria, 2008; 152(3): 321-326.
MAGGE SN, et al. Cardiometabolic Risk and Body Composition in Youth With Down Syndrome. Pediatrics, 2019; 144(2): 20190137.
MOREAU M, et al. Metabolic Diseases and Down Syndrome: How Are They Linked Together? Biomedicines, 2021; 9(2): 221.
MULLUR R, et al. Thyroid hormone regulation of metabolism. Physiological Reviews, 2014; 94(2): 355-382.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children,adolescents, and adults. Lancet, 2024; 403(10431): 1027-1050.
NOGUEIRA-DE-ALMEIDA CA, et al. Critério da Associação Brasileira de Nutrologia para diagnóstico e tratamento da síndrome metabólica em crianças e adolescentes. International Journal of Nutrology, 2020; 13(3): 54-68.
PALHARES HM, et al. Incidence of congenital hypothyroidism in the city of Uberaba/Minas Gerais and etiological evaluation of the affected subjects. Arquivos Brasileiros de Endocrinologia & Metabologia, 2012; 56(5): 305-312.
PALHARES HMDC, et al. Association between Acanthosis Nigricans and other Cardiometabolic Risk Factors in Children and Adolescents with Overweight and Obesity. Revista Paulista de Pediatria, 2018; 36(3): 301-308.
PALUMBO ML e McDougle CJ. Pharmacotherapy of Down syndrome. Expert Opinion on Pharmacotherapy, 2018; 19(17): 1875-1889.
PECORARO L, et al. Body composition and laboratory parameters in children with down syndrome: The DONUT study. Clinical Nutrition ESPEN, 2023; 57: 253-257.
SANTORO M, et al. Sex differences for major congenital heart defects in Down Syndrome: A population based study. European Journal of Medical Genetics, 2018; 61(9): 546-550.
SILVA APD, et al. Prevalence of overweight and obesity and associated factors in school children and adolescents in a medium-sized Brazilian city. Clinics (Sao Paulo), 2018; 73: 438.
SOBEY CG, et al. Risk of Major Cardiovascular Events in People with Down Syndrome. PLoS One, 2015; 10(9): 0137093.
VALENTINI D, et al. Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features. Jornal de Pediatria, 2017; 189: 92-971.
WANG F, et al. DUOX2 and DUOXA2 Variants Confer Susceptibility to Thyroid Dysgenesis and Gland-in-situ With Congenital Hypothyroidism. Frontiers in Endocrinology (Lausanne), 2020; 11: 237.
WHOOTEN R, et al. Endocrine manifestations of Down syndrome. Current Opinion in Endocrinology, Diabetes and Obesity, 2018; 25(1): 61-66.
WISNIEWSKI KE e Bobinski M. Hypothalamic abnormalities in Down syndrome. Progress in Clinical and Biological Research, 1991; 373: 153-167.
ZIMMERMANN MB, et al. New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. The American Journal of Clinical Nutrition, 2004; 79(2): 231-237.